Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines
A. Jones et al., Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines, CLIN CANC R, 7(5), 2001, pp. 1263-1272
Hypoxia is an important regulator of vascular endothelial growth factor (VE
GF) expression, and VEGF is associated with poor prognosis in bladder cance
r. To investigate further the mechanisms of VEGF regulation, we examined VE
GF expression by mRNA and protein analysis in four human bladder cancer cel
l lines, shelving a progression from well to poorly differentiated phenotyp
es under varying conditions of confluence and hypoxia (0.1% O-2) and with c
hemical mimic of hypoxia, Hypoxia significantly increased VEGF protein expr
ession in all cell lines, although this effect was dependent on the degree
of confluence. The superficial bladder cancer cell line RT4 lost hypoxia in
ducibility at confluence, whereas inducibility was maintained in the invasi
ve cell lines 253J and EJ28, This pattern of VEGF expression in the invasiv
e cell Lines correlated with the expression of the transcription factor hyp
oxia inducible factor-1 alpha (HIF-1 alpha) and with hypoxia-inducible fact
or-2 alpha. (HIF-2 alpha) and in RT4 correlated with a marked reduction in
HIF-1 alpha inducibility at confluence. Using the phosphatidylinositol 3-ki
nase (PI 3-kinase) inhibitor LY 294002, we show that this VEGF hypoxia-indu
cible pathway regulated by HIF-1 alpha is distinct from a PI 3-kinase-depen
dent pathway, which regulates basal amounts of VEGF, but does not affect in
ducibility, Both HIF-1 alpha and HIF-2 alpha protein and mRNA were up-regul
ated in primary human bladder tumors (n = 12) compared with normal bladder
specimens (n = 4), with significant intertumor variation. These results sug
gest that components of the hypoxia response pathway, including HIF-1 alpha
and HIF-2 alpha, are important cofactors in the regulation of VEGF in blad
der cancer and are therapeutic targets in this disease.